Emcure Pharmaceuticals has received approval from the Securities and Exchange Board of India (SEBI) to launch an initial public offering (IPO) valued at ₹800 crore. The IPO includes a fresh issuance of equity shares worth ₹800 crore and an Offer for Sale (OFS) of 1.36 crore shares by existing shareholders. This move follows an earlier filing in 2021, where the fresh issue component was ₹1,100 crore. The funds raised will primarily be used to repay debt, which will significantly reduce the company's financial liabilities and enhance its growth potential.